CD44 and nasopharyngeal carcinoma: Noteworthy, CD44 acts as stem cell surface marker in both nasopharyngeal carcinoma and gastric cancer [36, 37], the inhibition of CD44 expression by grifolin may contribute to its inhibitory effect on tumor invasion.